Publicacions<\/h2>\n\t\t\t\t![\"119-neurooncologia-jbruna-def\"](\"https:\/\/idibell.cat\/wp-content\/uploads\/2020\/04\/119-neurooncologia-jbruna-def.jpg\" "\\"119-neurooncologia-jbruna-def\\"")
\n\t\t\t\t\tL\u00ednies estrat\u00e8giques<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tAvaluaci\u00f3 de nous f\u00e0rmacs i nous enfocaments de tractament contra gliomes i meningiomes (Jordi Bruna, Carles Mesia, Ana Lucas, Carles Maj\u00f3s, Gerard Plans)
\nNeuropaties perif\u00e8riques indu\u00efdes per quimioter\u00e0pia (Jordi Bruna, Roser Velasco)
\nC\u00e0ncer i cognici\u00f3 (Marta Sim\u00f3)
\nMet\u00e0stasis leptomen\u00edngees (Jordi Bruna)
\nFactors pron\u00f2stics de superviv\u00e8ncia implicats en els tumors del sistema nervi\u00f3s central (Noem\u00ed Vidal, Jordi Bruna, Carles Maj\u00f3s. Albert Pons, Gerard Plans)
\nPrevenci\u00f3 i tractament personalitzat de met\u00e0stasis cerebrals: desenvolupament de noves ter\u00e0pies basades en la prevenci\u00f3 i pron\u00f2stic de biomarcadors (Carles Mesia, Noem\u00ed Vidal, Gerard Plans, Ana Lucas)
\nValoraci\u00f3 quantitativa de t\u00e8cniques avan\u00e7ades de RM en neurooncologia cl\u00ednica (Carles Majos, Albert Pons)\n\t\t\t\t\tPublicacions seleccionades<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tCalls A, Torres Espin A, Tormo M, Martinez Escardo L, Bonet N, Casals F, Navarro X, Yuste VJ, Udina E, Bruna J. A transient inflammatory response contributes to oxaliplatin neurotoxicity in mice<\/strong>. Ann. Clin. Transl. Neurol. 2022;9(12):1985-1998. doi:10.1002\/acn3.51691.<\/p>\nPons Escoda A, Garcia Ruiz A, Naval Baudin P, Grussu F, Fernandez JJS, Simo AC, Sarro NV, Fernandez Coello A, Bruna J, Cos M, Perez Lopez R, Majos C. Voxel-level analysis of normalized DSC-PWI time-intensity curves: a potential generalizable approach and its proof of concept in discriminating glioblastoma and metastasis<\/strong>. Eur Radiol. 2022;32(6):3705-3715. doi:10.1007\/s00330-021-08498-1.<\/p>\nPreusser M, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepulveda JM, Brandal P, Brazil L, Bonneville Levard A, Lorgis V, Vauleon E, Bromberg J, Erridge S, Cameron A, Lefranc F, Clement PM, Dumont S, Sanson M, Bronnimann C, Balan\u00e1 C, Thon N, Lewis J, Mair MJ, Sievers P, Furtner J, Pichler J, Bruna J, Ducray F, Reijneveld JC, Mawrin C, Bendszus M, Marosi C, Golfinopoulos V, Coens C, Gorlia T, Weller M, Sahm F, Wick W. Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG)<\/strong>. Neuro-Oncology. 2022;24(5):755-767. doi:10.1093\/neuonc\/noab243.<\/p>\nKarteri S, Bruna J, Argyriou AA, Mariotto S, Velasco R, Alemany M, Kalofonou F, Alberti P, Dinoto A, Velissaris D, Stradella A, Cavaletti G, Ferrari S, Kalofonos HP. Prospectively Assessing Serum Neurofilament Light Chain Levels As A Biomarker Of Paclitaxel-Induced Peripheral Neurotoxicity In Breast Cancer Patients<\/strong>. J. Peripher. Nerv. Syst. 2022;27(2):166-174. doi:10.1111\/jns.12493.<\/p>\nMao X, Wu S, Calero P\u00e9rez P, Candiota AP, Alfonso P, Bruna J, Yuste VJ, Lorenzo J, Novio F, Ruiz Molina D. Synthesis and Validation of a Bioinspired Catechol-Functionalized Pt(IV) Prodrug for Preclinical Intranasal Glioblastoma Treatment<\/strong>. Cancers. 2022;14(2):doi:10.3390\/cancers14020410.<\/p>\n\t\t\t\t\tProjectes seleccionats<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tFIS21056. Comprensi\u00f3n y modulaci\u00f3n de los mecanismos de respuesta senescente en la neuropat\u00eda inducida por platinos<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 172957,4. 2022-2024. PI: Bruna Escuer, Jordi.<\/p>\n21FIS037. Valoraci\u00f3n pron\u00f3stica de los gliomas cerebrales mediante espectroscopia por RMI (MRS-PROG)<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 58080. 2021-2023. PI: Majos Torro, Carles.<\/p>\n21FIS039. Neurotoxicidad inducida por quimioterapia y estado nutricional: biomarcadores cl\u00ednicos, s\u00e9ricos, radiol\u00f3gicos y neurofisiol\u00f3gicos asociados al desarrollo y la regeneraci\u00f3n nerviosa<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 93170. 2021-2023. PI: Velasco Fargas, Roser.<\/p>\n19FIS035. C\u00e1ncer de pulm\u00f3n y toxicidad cognitiva: marcadores serol\u00f3gicos y de neuroimagen de disrupci\u00f3n de la barrera hemato-encef\u00e1lica<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 93170. 2019-2023. PI: Sim\u00f3 Parra, Marta.<\/p>\n18ACL042. FASE III MULTIC\u00c9NTRICA, RANDOMIZADA DEL ESTUDIO PARA RADIOTERAPIA INTRAOPERATIVA EN CASO DE GLIOBLASTOMA MULTIFORME DE DIAGN\u00d3STICO NUEVO<\/strong>. Budget: 2000. 2018-2022. PI: Lucas Calduch, Anna.<\/p>\n\t\t\t\t\tM\u00e9s informaci\u00f3<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tIdentificaci\u00f3 de marcadors de risc predictiu cl\u00ednic i neurofisiol\u00f2gic per desenvolupar neuropatia indu\u00efda per oxaliplat\u00ed
\nNoves demostracions sobre l’efic\u00e0cia del nou antagonista del receptor sigma-1 per prevenir la neuropatia aguda de oxaliplat\u00ed en un estudi aleatoritzat de fase 2
\nDocumentaci\u00f3 dels canvis longitudinals del cervell associats amb la irradiaci\u00f3 cerebral profil\u00e0ctica i la quimioter\u00e0pia en pacients amb c\u00e0ncer de pulm\u00f3 de c\u00e8l\u00b7lules petites
\nIdentificaci\u00f3 d’un tret com\u00fa en glioblastomes: la defici\u00e8ncia intr\u00ednseca de la endonucleasa DFF40 \/ CAD que afecta la hidr\u00f2lisi de l’ADN durant la mort cel\u00b7lular caspasa-dependent\n\t\t\t\t![\"Jordi-Bruna22\"](\"https:\/\/idibell.cat\/wp-content\/uploads\/2022\/10\/Jordi-Bruna22-150x150.jpg\" "\\"Jordi-Bruna22\\"")
\n\n\t\tBruna Escuer, Jordi\n\t<\/h4>\n\n\t\t\n\t\tjbruna@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\n\t\tInvestigadors principals\n\t<\/h2>\n\t\t\t\t\n\n\t\tBruna Escuer, Jordi\n\t<\/h4>\n\n\t\t\n\t\tjbruna@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t![\"Marta-Simo\"](\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/02\/Marta-Simo-150x150.jpg\" "\\"Marta-Simo\\"")
\n\n\t\tSimo Parra, Marta\n\t<\/h4>\n\n\t\t\n\t\tmsimo@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t![\"Carlos-Mesia-Barroso\"](\"https:\/\/idibell.cat\/wp-content\/uploads\/2020\/11\/Carlos-Mesia-Barroso-150x150.jpg\" "\\"Carlos-Mesia-Barroso\\"")
\n\n\t\tMesia Barroso, Carlos\n\t<\/h4>\n\n\t\t\n\t\tcmesia@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t![\"Anna-Lucas-Calduch\"](\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/05\/Anna-Lucas-Calduch-150x150.jpg\" "\\"Anna-Lucas-Calduch\\"")
\n\n\t\tLucas Calduch, Anna Maria\n\t<\/h4>\n\n\t\t\n\t\talucas@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t![\"Roser-Velasco-Fargas\"](\"https:\/\/idibell.cat\/wp-content\/uploads\/2020\/11\/Roser-Velasco-Fargas-150x150.jpg\" "\\"Roser-Velasco-Fargas\\"")
\n\n\t\tVelasco Fargas, Roser\n\t<\/h4>\n\n\t\t\n\t\trvelasco@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t![\"Carles-Majos-Torro\"](\"https:\/\/idibell.cat\/wp-content\/uploads\/2021\/05\/Carles-Majos-Torro-150x150.jpg\" "\\"Carles-Majos-Torro\\"")
\n\n\t\tMajos Torro, Carlos\n\t<\/h4>\n\n\t\t\n\t\tcmajos@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\n\t\tENLLA\u00c7OS RELACIONATS\n\t<\/h4>\n\n\t\t\n\t\t@VelascoRoser\n\t\t<\/a>\n\t<\/h4>\n\n\t\tEquip\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tCaps de grup\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es principals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es cl\u00ednics\/ques\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es predoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tSuport de gesti\u00f3\t\t\t\t<\/a>\n\t\t\t\t\t\tCaps de grup\n\t\t\t\t\t\t\t\t\t\t\t\n- Bruna Escuer, Jordi<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadors\/es principals\n\t\t\t\t\t\t\t\t\t\t\t
\n- Velasco Fargas, Roser<\/li>\n
- Mesia Barroso, Carlos<\/li>\n
- Simo Parra, Marta<\/li>\n
- Majos Torro, Carlos<\/li>\n
- Lucas Calduch, Anna Maria<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadors\/es cl\u00ednics\/ques\n\t\t\t\t\t\t\t\t\t\t\t
\n- Fern\u00e1ndez Coello, Alejandro<\/li>\n
- Aguilera Grijalbo, Carlos<\/li>\n
- Vidal Sarro, Noemi<\/li>\n
- Plans Ahicart, Gerard<\/li>\n
- Pons Escoda, Albert<\/li>\n<\/ul>\n\t\t\t\t\t\tInvestigadors\/es predoctorals\n\t\t\t\t\t\t\t\t\t\t\t
\n- Alemany\u00a0 Mart\u00ed, Montserrat<\/li>\n
- Septien Rivera, Sara<\/li>\n<\/ul>\n\t\t\t\t\t\tSuport de gesti\u00f3\n\t\t\t\t\t\t\t\t\t\t\t
\n- Sala Corominas, Ros\u00f3<\/li>\n<\/ul>\n
\n\t\tNot\u00edcies relacionades\n\t<\/h2>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUna nova eina basada en la Intel\u2022lig\u00e8ncia Artificial permetr\u00e0 millorar el diagn\u00f2stic de tumors cerebrals<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t12\/03\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tPrimer assaig cl\u00ednic d’un tractament que ataca el c\u00e0ncer de pulm\u00f3 i la met\u00e0stasi al cervell a la vegada<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t22\/08\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tL’estudi de lesions cerebrals revela connexions neuronals clau en l’epil\u00e8psia<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t21\/07\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl diagn\u00f2stic i tractament del glioblastoma durant la crisi financera del 2008 i la pand\u00e8mia de COVID-19<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t17\/02\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tAconsegueixen activar una prote\u00efna clau per completar el proc\u00e9s de mort per apoptosi en c\u00e8l\u00b7lules de glioblastoma<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t24\/11\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tL’exercici evita el dany neuronal causat per la ter\u00e0pia contra el c\u00e0ncer de pulm\u00f3<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t03\/06\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tIDIBELL celebra el Kickoff Meeting sobre els Projectes d’Investigaci\u00f3 en Salut concedits per l’ISCIII<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t20\/04\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tDefineixen les caracter\u00edstiques cl\u00edniques de les complicacions cerebrals causades per immunoter\u00e0pies oncol\u00f2giques que en determinen l’evoluci\u00f3<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t30\/03\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEls supervivents de tumors cerebrals oligodendroglials corren el risc de desenvolupar deteriorament cognitiu a llarg termini<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t09\/10\/2019\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl c\u00e0ncer de tu a tu: Pacients, metges, investigadors i activistes de la lluita contra el c\u00e0ncer dialoguen i s’obren a la ciutadania<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t13\/09\/2018\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"Neuro-oncologia Resum El grup de Neuro-Oncologia se centra en l’estudi dels tractaments de tumors cerebrals i les complicacions neurol\u00f2giques relacionades amb el c\u00e0ncer i els tractaments contra el c\u00e0ncer. L’objectiu del grup \u00e9s crear i refor\u00e7ar una xarxa de recerca entre investigadors cl\u00ednics i precl\u00ednics tant dins com fora de la instituci\u00f3,\u00a0 per proporcionar noves […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":448,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2024-05-11 00:50:38","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/1916"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=1916"}],"version-history":[{"count":6,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/1916\/revisions"}],"predecessor-version":[{"id":25403,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/1916\/revisions\/25403"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/448"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=1916"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Pons Escoda A, Garcia Ruiz A, Naval Baudin P, Grussu F, Fernandez JJS, Simo AC, Sarro NV, Fernandez Coello A, Bruna J, Cos M, Perez Lopez R, Majos C. Voxel-level analysis of normalized DSC-PWI time-intensity curves: a potential generalizable approach and its proof of concept in discriminating glioblastoma and metastasis<\/strong>. Eur Radiol. 2022;32(6):3705-3715. doi:10.1007\/s00330-021-08498-1.<\/p>\n Preusser M, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepulveda JM, Brandal P, Brazil L, Bonneville Levard A, Lorgis V, Vauleon E, Bromberg J, Erridge S, Cameron A, Lefranc F, Clement PM, Dumont S, Sanson M, Bronnimann C, Balan\u00e1 C, Thon N, Lewis J, Mair MJ, Sievers P, Furtner J, Pichler J, Bruna J, Ducray F, Reijneveld JC, Mawrin C, Bendszus M, Marosi C, Golfinopoulos V, Coens C, Gorlia T, Weller M, Sahm F, Wick W. Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG)<\/strong>. Neuro-Oncology. 2022;24(5):755-767. doi:10.1093\/neuonc\/noab243.<\/p>\n Karteri S, Bruna J, Argyriou AA, Mariotto S, Velasco R, Alemany M, Kalofonou F, Alberti P, Dinoto A, Velissaris D, Stradella A, Cavaletti G, Ferrari S, Kalofonos HP. Prospectively Assessing Serum Neurofilament Light Chain Levels As A Biomarker Of Paclitaxel-Induced Peripheral Neurotoxicity In Breast Cancer Patients<\/strong>. J. Peripher. Nerv. Syst. 2022;27(2):166-174. doi:10.1111\/jns.12493.<\/p>\n Mao X, Wu S, Calero P\u00e9rez P, Candiota AP, Alfonso P, Bruna J, Yuste VJ, Lorenzo J, Novio F, Ruiz Molina D. Synthesis and Validation of a Bioinspired Catechol-Functionalized Pt(IV) Prodrug for Preclinical Intranasal Glioblastoma Treatment<\/strong>. Cancers. 2022;14(2):doi:10.3390\/cancers14020410.<\/p>\n\t\t\t\t\tProjectes seleccionats<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t FIS21056. Comprensi\u00f3n y modulaci\u00f3n de los mecanismos de respuesta senescente en la neuropat\u00eda inducida por platinos<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 172957,4. 2022-2024. PI: Bruna Escuer, Jordi.<\/p>\n 21FIS037. Valoraci\u00f3n pron\u00f3stica de los gliomas cerebrales mediante espectroscopia por RMI (MRS-PROG)<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 58080. 2021-2023. PI: Majos Torro, Carles.<\/p>\n 21FIS039. Neurotoxicidad inducida por quimioterapia y estado nutricional: biomarcadores cl\u00ednicos, s\u00e9ricos, radiol\u00f3gicos y neurofisiol\u00f3gicos asociados al desarrollo y la regeneraci\u00f3n nerviosa<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 93170. 2021-2023. PI: Velasco Fargas, Roser.<\/p>\n 19FIS035. C\u00e1ncer de pulm\u00f3n y toxicidad cognitiva: marcadores serol\u00f3gicos y de neuroimagen de disrupci\u00f3n de la barrera hemato-encef\u00e1lica<\/strong>. Instituto de Salud Carlos III (ISCIII). Budget: 93170. 2019-2023. PI: Sim\u00f3 Parra, Marta.<\/p>\n 18ACL042. FASE III MULTIC\u00c9NTRICA, RANDOMIZADA DEL ESTUDIO PARA RADIOTERAPIA INTRAOPERATIVA EN CASO DE GLIOBLASTOMA MULTIFORME DE DIAGN\u00d3STICO NUEVO<\/strong>. Budget: 2000. 2018-2022. PI: Lucas Calduch, Anna.<\/p>\n\t\t\t\t\tM\u00e9s informaci\u00f3<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tIdentificaci\u00f3 de marcadors de risc predictiu cl\u00ednic i neurofisiol\u00f2gic per desenvolupar neuropatia indu\u00efda per oxaliplat\u00ed Neuro-oncologia Resum El grup de Neuro-Oncologia se centra en l’estudi dels tractaments de tumors cerebrals i les complicacions neurol\u00f2giques relacionades amb el c\u00e0ncer i els tractaments contra el c\u00e0ncer. L’objectiu del grup \u00e9s crear i refor\u00e7ar una xarxa de recerca entre investigadors cl\u00ednics i precl\u00ednics tant dins com fora de la instituci\u00f3,\u00a0 per proporcionar noves […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":448,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"disabled","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"publishpress_future_action":{"enabled":false,"date":"2024-05-11 00:50:38","action":"change-status","newStatus":"draft","terms":[],"taxonomy":""},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/1916"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=1916"}],"version-history":[{"count":6,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/1916\/revisions"}],"predecessor-version":[{"id":25403,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/1916\/revisions\/25403"}],"up":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/pages\/448"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=1916"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nNoves demostracions sobre l’efic\u00e0cia del nou antagonista del receptor sigma-1 per prevenir la neuropatia aguda de oxaliplat\u00ed en un estudi aleatoritzat de fase 2
\nDocumentaci\u00f3 dels canvis longitudinals del cervell associats amb la irradiaci\u00f3 cerebral profil\u00e0ctica i la quimioter\u00e0pia en pacients amb c\u00e0ncer de pulm\u00f3 de c\u00e8l\u00b7lules petites
\nIdentificaci\u00f3 d’un tret com\u00fa en glioblastomes: la defici\u00e8ncia intr\u00ednseca de la endonucleasa DFF40 \/ CAD que afecta la hidr\u00f2lisi de l’ADN durant la mort cel\u00b7lular caspasa-dependent\n\t\t\t\t\n\n\t\tBruna Escuer, Jordi\n\t<\/h4>\n
\n\t\t\n\t\tjbruna@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tInvestigadors principals\n\t<\/h2>\n\t\t\t\t
\n\n\t\tBruna Escuer, Jordi\n\t<\/h4>\n
\n\t\t\n\t\tjbruna@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t
\n\n\t\tSimo Parra, Marta\n\t<\/h4>\n
\n\t\t\n\t\tmsimo@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t
\n\n\t\tMesia Barroso, Carlos\n\t<\/h4>\n
\n\t\t\n\t\tcmesia@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t
\n\n\t\tLucas Calduch, Anna Maria\n\t<\/h4>\n
\n\t\t\n\t\talucas@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t
\n\n\t\tVelasco Fargas, Roser\n\t<\/h4>\n
\n\t\t\n\t\trvelasco@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n\t\t\t\t
\n\n\t\tMajos Torro, Carlos\n\t<\/h4>\n
\n\t\t\n\t\tcmajos@idibell.cat\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tENLLA\u00c7OS RELACIONATS\n\t<\/h4>\n
\n\t\t\n\t\t@VelascoRoser\n\t\t<\/a>\n\t<\/h4>\n
\n\t\tEquip\n\t<\/h2>\n\t\t\t\t\t\t\t\t\t\t\t\tCaps de grup\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es principals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es cl\u00ednics\/ques\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tInvestigadors\/es predoctorals\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t\t\t\t\tSuport de gesti\u00f3\t\t\t\t<\/a>\n\t\t\t\t\t\tCaps de grup\n\t\t\t\t\t\t\t\t\t\t\t
\n
\n
\n
\n
\n
\n\t\tNot\u00edcies relacionades\n\t<\/h2>\n\t\t\n\t\t\t\t<\/a>\n\t\t\tUna nova eina basada en la Intel\u2022lig\u00e8ncia Artificial permetr\u00e0 millorar el diagn\u00f2stic de tumors cerebrals<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t12\/03\/2024\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tPrimer assaig cl\u00ednic d’un tractament que ataca el c\u00e0ncer de pulm\u00f3 i la met\u00e0stasi al cervell a la vegada<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t22\/08\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tL’estudi de lesions cerebrals revela connexions neuronals clau en l’epil\u00e8psia<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t21\/07\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl diagn\u00f2stic i tractament del glioblastoma durant la crisi financera del 2008 i la pand\u00e8mia de COVID-19<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t17\/02\/2023\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tAconsegueixen activar una prote\u00efna clau per completar el proc\u00e9s de mort per apoptosi en c\u00e8l\u00b7lules de glioblastoma<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t24\/11\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tL’exercici evita el dany neuronal causat per la ter\u00e0pia contra el c\u00e0ncer de pulm\u00f3<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t03\/06\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tIDIBELL celebra el Kickoff Meeting sobre els Projectes d’Investigaci\u00f3 en Salut concedits per l’ISCIII<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t20\/04\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tDefineixen les caracter\u00edstiques cl\u00edniques de les complicacions cerebrals causades per immunoter\u00e0pies oncol\u00f2giques que en determinen l’evoluci\u00f3<\/a>\n\t\t\tBy comunicacio<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t30\/03\/2021\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEls supervivents de tumors cerebrals oligodendroglials corren el risc de desenvolupar deteriorament cognitiu a llarg termini<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t09\/10\/2019\t\t\t\t\t\t\t\n\t\t\n\t\t\t\t<\/a>\n\t\t\tEl c\u00e0ncer de tu a tu: Pacients, metges, investigadors i activistes de la lluita contra el c\u00e0ncer dialoguen i s’obren a la ciutadania<\/a>\n\t\t\tBy Idibell<\/a>\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t | \n\t\t\t\t\t\t\t\t\t13\/09\/2018\t\t\t\t\t\t\t\n\t\t\n\n","protected":false},"excerpt":{"rendered":"